World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 19 April 2022
Main ID:  ISRCTN22890916
Date of registration: 28/09/2007
Prospective Registration: Yes
Primary sponsor: Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Public title: The effective management of radiation-induced bowel injury: a randomised controlled trial
Scientific title: The effective management of radiation-induced bowel injury: a randomised controlled trial
Date of first enrolment: 26/11/2007
Target sample size: 250
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN22890916
Study type:  Interventional
Study design:  Randomised controlled trial (Quality of life)  
Phase:  Not Applicable
Countries of recruitment
England United Kingdom
Contacts
Name: Jervoise    Andreyev
Address:  Gastrointestinal Unit, Department of Medicine Royal Marsden NHS Trust Fulham Road SW3 6JJ London United Kingdom
Telephone: +44 020 7808 2105
Email: j@andreyev.demon.co.uk
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients who have a life expectancy of more than 1 year and who have received radical pelvic radiotherapy with curative intent six months previously and who subsequently have developed new onset troublesome gastrointestinal symptoms
Exclusion criteria:
Added May 2008:
1. Patient refusing to give informed consent
2. Patients deemed by their clinical oncologist to require immediate gastroenterological assessment


Age minimum:
Age maximum:
Gender: Not Specified
Health Condition(s) or Problem(s) studied
Injury, Occupational Diseases, Poisoning: Radiation
Injury, Occupational Diseases, Poisoning
Radiation
Intervention(s)

Randomised test intervention vs standardised intervention, non-blinded (Phase III).
Observational (no treatment or diagnostic intervention), Quality of Life Assessment, Qualitative Study
Primary Outcome(s)
Improvement in gastrointestinal symptoms
Secondary Outcome(s)
Not provided at time of registration
Secondary ID(s)
N0258191022
Source(s) of Monetary Support
The Royal Marsden NHS Foundation Trust (UK)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
The Royal Marsden Research Ethics Committee (now merged with South West London REC1), 26/03/2007, ref: 07/Q0801/47
Results
Results available: Yes
Date Posted:
Date Completed: 31/07/2012
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history